25 XP   0   0   10

Aravive Inc
Buy, Hold or Sell?

Let's analyze Aravive together

I guess you are interested in Aravive Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aravive Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aravive Inc

I send you an email if I find something interesting about Aravive Inc.

Quick analysis of Aravive (30 sec.)










What can you expect buying and holding a share of Aravive? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.14
Expected worth in 1 year
$-1.57
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-1.72
Return On Investment
-4,280.2%

For what price can you sell your share?

Current Price per Share
$0.04
Expected price per share
$0 - $0.1277
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Aravive (5 min.)




Live pricePrice per Share (EOD)

$0.04

Intrinsic Value Per Share

$-12.50 - $3.10

Total Value Per Share

$-12.36 - $3.25

2. Growth of Aravive (5 min.)




Is Aravive growing?

Current yearPrevious yearGrowGrow %
How rich?$10.6m$42.2m-$31.5m-296.2%

How much money is Aravive making?

Current yearPrevious yearGrowGrow %
Making money-$80.9m-$38.1m-$42.7m-52.9%
Net Profit Margin-885.6%-512.5%--

How much money comes from the company's main activities?

3. Financial Health of Aravive (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#628 / 966

Most Revenue
#288 / 966

Most Profit
#915 / 966

Most Efficient
#719 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Aravive? (5 min.)

Welcome investor! Aravive's management wants to use your money to grow the business. In return you get a share of Aravive.

What can you expect buying and holding a share of Aravive?

First you should know what it really means to hold a share of Aravive. And how you can make/lose money.

Speculation

The Price per Share of Aravive is $0.0401. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aravive.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aravive, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.14. Based on the TTM, the Book Value Change Per Share is $-0.43 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aravive.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.04-2,587.3%-1.04-2,587.3%-0.53-1,327.2%-0.65-1,631.0%-0.82-2,051.3%
Usd Book Value Change Per Share-0.43-1,070.1%-0.43-1,070.1%-0.08-197.7%-0.20-488.8%0.0253.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.43-1,070.1%-0.43-1,070.1%-0.08-197.7%-0.20-488.8%0.0253.4%
Usd Price Per Share1.32-1.32-2.23-5.28-7.83-
Price to Earnings Ratio-1.27--1.27--4.19--15.53--12.20-
Price-to-Total Gains Ratio-3.08--3.08--28.12-9.63-12.56-
Price to Book Ratio9.11-9.11-3.89-8.10-6.48-
Price-to-Total Gains Ratio-3.08--3.08--28.12-9.63-12.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0401
Number of shares24937
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.43-0.20
Usd Total Gains Per Share-0.43-0.20
Gains per Quarter (24937 shares)-10,700.23-4,888.17
Gains per Year (24937 shares)-42,800.90-19,552.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-42801-428110-19553-19563
20-85602-856120-39105-39116
30-128403-1284130-58658-58669
40-171204-1712140-78211-78222
50-214005-2140150-97763-97775
60-256805-2568160-117316-117328
70-299606-2996170-136869-136881
80-342407-3424180-156421-156434
90-385208-3852190-175974-175987
100-428009-4280200-195527-195540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%5.07.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%5.07.00.041.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Aravive

About Aravive Inc

Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a license and collaboration agreement with WuXi Biologics (Hong Kong) Limited to identify and develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

Fundamental data was last updated by Penke on 2024-07-01 00:08:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Aravive Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aravive earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • A Net Profit Margin of -885.6% means that $-8.86 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aravive Inc:

  • The MRQ is -885.6%. The company is making a huge loss. -2
  • The TTM is -885.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-885.6%TTM-885.6%0.0%
TTM-885.6%YOY-512.5%-373.1%
TTM-885.6%5Y-1,598.9%+713.2%
5Y-1,598.9%10Y-820.7%-778.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-885.6%-168.0%-717.6%
TTM-885.6%-209.9%-675.7%
YOY-512.5%-242.3%-270.2%
5Y-1,598.9%-401.7%-1,197.2%
10Y-820.7%-532.2%-288.5%
1.1.2. Return on Assets

Shows how efficient Aravive is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • -130.2% Return on Assets means that Aravive generated $-1.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aravive Inc:

  • The MRQ is -130.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -130.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-130.2%TTM-130.2%0.0%
TTM-130.2%YOY-56.3%-73.9%
TTM-130.2%5Y-74.3%-55.9%
5Y-74.3%10Y-71.2%-3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-130.2%-11.9%-118.3%
TTM-130.2%-11.9%-118.3%
YOY-56.3%-11.3%-45.0%
5Y-74.3%-13.5%-60.8%
10Y-71.2%-14.9%-56.3%
1.1.3. Return on Equity

Shows how efficient Aravive is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • -759.3% Return on Equity means Aravive generated $-7.59 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aravive Inc:

  • The MRQ is -759.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -759.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-759.3%TTM-759.3%0.0%
TTM-759.3%YOY-90.3%-669.0%
TTM-759.3%5Y-215.5%-543.8%
5Y-215.5%10Y-149.7%-65.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-759.3%-14.2%-745.1%
TTM-759.3%-15.7%-743.6%
YOY-90.3%-14.3%-76.0%
5Y-215.5%-19.2%-196.3%
10Y-149.7%-19.7%-130.0%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Aravive Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aravive is operating .

  • Measures how much profit Aravive makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • An Operating Margin of -775.3% means the company generated $-7.75  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aravive Inc:

  • The MRQ is -775.3%. The company is operating very inefficient. -2
  • The TTM is -775.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-775.3%TTM-775.3%0.0%
TTM-775.3%YOY-546.2%-229.1%
TTM-775.3%5Y-998.9%+223.6%
5Y-998.9%10Y-520.6%-478.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-775.3%-354.6%-420.7%
TTM-775.3%-225.9%-549.4%
YOY-546.2%-252.2%-294.0%
5Y-998.9%-428.3%-570.6%
10Y-520.6%-531.1%+10.5%
1.2.2. Operating Ratio

Measures how efficient Aravive is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 16.08 means that the operating costs are $16.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aravive Inc:

  • The MRQ is 16.079. The company is inefficient in keeping operating costs low. -1
  • The TTM is 16.079. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16.079TTM16.0790.000
TTM16.079YOY11.507+4.572
TTM16.0795Y15.736+0.343
5Y15.73610Y8.409+7.327
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0793.004+13.075
TTM16.0793.332+12.747
YOY11.5073.502+8.005
5Y15.7365.271+10.465
10Y8.4096.915+1.494
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Aravive Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aravive is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.73 means the company has $2.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aravive Inc:

  • The MRQ is 2.733. The company is able to pay all its short-term debts. +1
  • The TTM is 2.733. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.733TTM2.7330.000
TTM2.733YOY3.223-0.490
TTM2.7335Y13.456-10.723
5Y13.45610Y13.432+0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7333.767-1.034
TTM2.7334.000-1.267
YOY3.2234.905-1.682
5Y13.4565.883+7.573
10Y13.4326.286+7.146
1.3.2. Quick Ratio

Measures if Aravive is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • A Quick Ratio of 2.62 means the company can pay off $2.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aravive Inc:

  • The MRQ is 2.618. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.618. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.618TTM2.6180.000
TTM2.618YOY3.098-0.480
TTM2.6185Y13.438-10.819
5Y13.43810Y13.398+0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6183.054-0.436
TTM2.6183.506-0.888
YOY3.0984.756-1.658
5Y13.4385.757+7.681
10Y13.3986.338+7.060
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Aravive Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aravive assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aravive to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.83 means that Aravive assets are financed with 82.9% credit (debt) and the remaining percentage (100% - 82.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aravive Inc:

  • The MRQ is 0.829. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.829. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.829TTM0.8290.000
TTM0.829YOY0.377+0.451
TTM0.8295Y0.358+0.470
5Y0.35810Y0.253+0.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8290.330+0.499
TTM0.8290.342+0.487
YOY0.3770.287+0.090
5Y0.3580.368-0.010
10Y0.2530.382-0.129
1.4.2. Debt to Equity Ratio

Measures if Aravive is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aravive to the Biotechnology industry mean.
  • A Debt to Equity ratio of 483.2% means that company has $4.83 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aravive Inc:

  • The MRQ is 4.832. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.832. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.832TTM4.8320.000
TTM4.832YOY0.605+4.227
TTM4.8325Y1.239+3.593
5Y1.23910Y0.715+0.524
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8320.365+4.467
TTM4.8320.415+4.417
YOY0.6050.370+0.235
5Y1.2390.443+0.796
10Y0.7150.476+0.239
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Aravive Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aravive generates.

  • Above 15 is considered overpriced but always compare Aravive to the Biotechnology industry mean.
  • A PE ratio of -1.27 means the investor is paying $-1.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aravive Inc:

  • The EOD is -0.039. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.272. Based on the earnings, the company is expensive. -2
  • The TTM is -1.272. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.039MRQ-1.272+1.234
MRQ-1.272TTM-1.2720.000
TTM-1.272YOY-4.190+2.918
TTM-1.2725Y-15.527+14.255
5Y-15.52710Y-12.195-3.332
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.039-2.341+2.302
MRQ-1.272-2.997+1.725
TTM-1.272-2.882+1.610
YOY-4.190-3.553-0.637
5Y-15.527-6.262-9.265
10Y-12.195-6.288-5.907
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aravive Inc:

  • The EOD is -0.045. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.492. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.492. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.045MRQ-1.492+1.447
MRQ-1.492TTM-1.4920.000
TTM-1.492YOY-5.098+3.606
TTM-1.4925Y-21.562+20.071
5Y-21.56210Y-19.006-2.557
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.045-2.932+2.887
MRQ-1.492-3.739+2.247
TTM-1.492-3.776+2.284
YOY-5.098-4.917-0.181
5Y-21.562-7.942-13.620
10Y-19.006-8.503-10.503
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aravive is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.11 means the investor is paying $9.11 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aravive Inc:

  • The EOD is 0.277. Based on the equity, the company is cheap. +2
  • The MRQ is 9.112. Based on the equity, the company is overpriced. -1
  • The TTM is 9.112. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.277MRQ9.112-8.835
MRQ9.112TTM9.1120.000
TTM9.112YOY3.885+5.226
TTM9.1125Y8.103+1.009
5Y8.10310Y6.476+1.627
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2771.843-1.566
MRQ9.1122.249+6.863
TTM9.1122.301+6.811
YOY3.8852.412+1.473
5Y8.1033.782+4.321
10Y6.4764.212+2.264
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aravive Inc.

3.1. Institutions holding Aravive Inc

Institutions are holding 8.209% of the shares of Aravive Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Acadian Asset Management LLC2.39110.00021758982-3100-0.1759
2024-03-31XTX Topco Ltd0.147401084401084400
2023-12-31JANE STREET GROUP, LLC0.0175012904129040
2024-03-31MASSMUTUAL TRUST CO FSB/ADV0.01260930000
2023-12-31Royal Bank of Canada0.00060440-75-14.5631
2024-03-31Affinity Asset Advisors, LLC000-346511-100
2024-03-31State Street Corporation000-79187-100
2024-03-31Susquehanna International Group, LLP000-25413-100
2024-03-31Wells Fargo & Co000-22811-100
2024-03-31Tower Research Capital LLC000-25744-100
2023-12-31Prudential Financial Inc000-259800-100
2024-03-31Northern Trust Corp000-74696-100
2024-03-31JustInvest LLC000-16083-100
2024-03-31SIMPLEX TRADING, LLC000-26682-100
2023-12-31Millennium Management LLC000-395797-100
2024-03-31BNP Paribas Arbitrage, SA000-346-100
2024-03-31Morgan Stanley - Brokerage Accounts000-3005-100
2024-03-31GSA Capital Partners LLP000-1977407-100
2024-03-31Virtu Financial LLC000-37611-100
2024-03-31Advisor Group Holdings, Inc.000-575-100
Total 2.56920.00021890066-3173499-167.9%

3.2. Funds holding Aravive Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv0.5009036850100
2024-04-30Fidelity Extended Market Index0.3578026323000
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.2026014901800
2023-09-30BlackRock Extended Mkt Composite0.13940.000110255900
2024-03-31BlackRock Extended Equity Market K0.1217089506320.0358
2024-04-30Fidelity Total Market Index0.062704616000
2024-04-30Fidelity Series Total Market Index0.057104197800
2024-04-30Spartan Total Market Index Pool E0.032202366900
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.0301022120221200
2024-03-31BlackRock U.S. Equity Market F0.0169012439124390
2024-03-31Extended Equity Market Fund M0.015011041110410
2024-03-31BNYM Mellon SL Market Completion UC10.00720.000153254285412.0192
2023-12-31SSgA U.S. Extended Market Index Class I0.00360261600
2024-05-31State St US Extended Mkt Indx NL Cl C0.00360261600
2023-12-31NT US Market Cap Idx Fd - L0.00180129000
2023-12-31SSgA U.S. Total Market Index Strategy0.0010755-17-2.2021
2024-05-31State St US Ttl Mkt Indx SL Cl I0.0004027200
2024-03-31BNYM Mellon NSL Mkt Completion Fund Inst0.0003021500
Total 1.55430.00021143310+49900+4.4%

3.3. Insider Transactions

Insiders are holding 38.688% of the shares of Aravive Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-11-30Amato GiacciaSELL32453.22
2021-06-29Gail Frances McintyreBUY10005.34
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Aravive Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.429-0.4290%-0.079-82%-0.196-54%0.021-2104%
Book Value Per Share--0.1450.1450%0.574-75%0.625-77%1.112-87%
Current Ratio--2.7332.7330%3.223-15%13.456-80%13.432-80%
Debt To Asset Ratio--0.8290.8290%0.377+120%0.358+131%0.253+227%
Debt To Equity Ratio--4.8324.8320%0.605+698%1.239+290%0.715+576%
Dividend Per Share----0%-0%-0%-0%
Eps---1.038-1.0380%-0.532-49%-0.654-37%-0.823-21%
Free Cash Flow Per Share---0.885-0.8850%-0.437-51%-0.429-51%-0.606-31%
Free Cash Flow To Equity Per Share---0.078-0.0780%-0.015-80%-0.089+14%0.069-214%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.105--------
Intrinsic Value_10Y_min---12.502--------
Intrinsic Value_1Y_max---0.270--------
Intrinsic Value_1Y_min---0.777--------
Intrinsic Value_3Y_max---0.369--------
Intrinsic Value_3Y_min---2.761--------
Intrinsic Value_5Y_max--0.067--------
Intrinsic Value_5Y_min---5.196--------
Market Cap2949860.260-3192%97102632.00097102632.0000%164044598.000-41%388116277.600-75%576142283.200-83%
Net Profit Margin---8.856-8.8560%-5.125-42%-15.989+81%-8.207-7%
Operating Margin---7.753-7.7530%-5.462-30%-9.989+29%-5.206-33%
Operating Ratio--16.07916.0790%11.507+40%15.736+2%8.409+91%
Pb Ratio0.277-3192%9.1129.1120%3.885+135%8.103+12%6.476+41%
Pe Ratio-0.039+97%-1.272-1.2720%-4.190+229%-15.527+1120%-12.195+859%
Price Per Share0.040-3192%1.3201.3200%2.230-41%5.276-75%7.832-83%
Price To Free Cash Flow Ratio-0.045+97%-1.492-1.4920%-5.098+242%-21.562+1345%-19.006+1174%
Price To Total Gains Ratio-0.093+97%-3.076-3.0760%-28.124+814%9.629-132%12.560-124%
Quick Ratio--2.6182.6180%3.098-15%13.438-81%13.398-80%
Return On Assets---1.302-1.3020%-0.563-57%-0.743-43%-0.712-45%
Return On Equity---7.593-7.5930%-0.903-88%-2.155-72%-1.497-80%
Total Gains Per Share---0.429-0.4290%-0.079-82%-0.196-54%0.021-2104%
Usd Book Value--10657000.00010657000.0000%42222000.000-75%45985600.000-77%81832000.000-87%
Usd Book Value Change Per Share---0.429-0.4290%-0.079-82%-0.196-54%0.021-2104%
Usd Book Value Per Share--0.1450.1450%0.574-75%0.625-77%1.112-87%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.038-1.0380%-0.532-49%-0.654-37%-0.823-21%
Usd Free Cash Flow---65090000.000-65090000.0000%-32177000.000-51%-31576600.000-51%-44588100.000-31%
Usd Free Cash Flow Per Share---0.885-0.8850%-0.437-51%-0.429-51%-0.606-31%
Usd Free Cash Flow To Equity Per Share---0.078-0.0780%-0.015-80%-0.089+14%0.069-214%
Usd Market Cap2949860.260-3192%97102632.00097102632.0000%164044598.000-41%388116277.600-75%576142283.200-83%
Usd Price Per Share0.040-3192%1.3201.3200%2.230-41%5.276-75%7.832-83%
Usd Profit---80921000.000-80921000.0000%-38140000.000-53%-49978200.000-38%-58887400.000-27%
Usd Revenue--9137000.0009137000.0000%7442000.000+23%5677600.000+61%6838800.000+34%
Usd Total Gains Per Share---0.429-0.4290%-0.079-82%-0.196-54%0.021-2104%
 EOD+3 -5MRQTTM+0 -0YOY+3 -305Y+6 -2710Y+2 -31

4.2. Fundamental Score

Let's check the fundamental score of Aravive Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.039
Price to Book Ratio (EOD)Between0-10.277
Net Profit Margin (MRQ)Greater than0-8.856
Operating Margin (MRQ)Greater than0-7.753
Quick Ratio (MRQ)Greater than12.618
Current Ratio (MRQ)Greater than12.733
Debt to Asset Ratio (MRQ)Less than10.829
Debt to Equity Ratio (MRQ)Less than14.832
Return on Equity (MRQ)Greater than0.15-7.593
Return on Assets (MRQ)Greater than0.05-1.302
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Aravive Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5020.542
Ma 20Greater thanMa 500.095
Ma 50Greater thanMa 1000.118
Ma 100Greater thanMa 2000.130
OpenGreater thanClose0.044
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets62,153
Total Liabilities51,496
Total Stockholder Equity10,657
 As reported
Total Liabilities 51,496
Total Stockholder Equity+ 10,657
Total Assets = 62,153

Assets

Total Assets62,153
Total Current Assets56,134
Long-term Assets6,019
Total Current Assets
Cash And Cash Equivalents 53,689
Net Receivables 85
Inventory -1,921
Other Current Assets 4,281
Total Current Assets  (as reported)56,134
Total Current Assets  (calculated)56,134
+/-0
Long-term Assets
Property Plant Equipment 1,462
Long-term Assets Other 4,557
Long-term Assets  (as reported)6,019
Long-term Assets  (calculated)6,019
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,538
Long-term Liabilities30,958
Total Stockholder Equity10,657
Total Current Liabilities
Short-term Debt 2,195
Accounts payable 8,765
Other Current Liabilities 4,543
Total Current Liabilities  (as reported)20,538
Total Current Liabilities  (calculated)15,503
+/- 5,035
Long-term Liabilities
Capital Lease Obligations 4,077
Other Liabilities 27,502
Long-term Liabilities  (as reported)30,958
Long-term Liabilities  (calculated)31,579
+/- 621
Total Stockholder Equity
Common Stock6
Retained Earnings -616,127
Capital Surplus 626,778
Total Stockholder Equity (as reported)10,657
Total Stockholder Equity (calculated)10,657
+/-0
Other
Capital Stock6
Cash and Short Term Investments 53,689
Common Stock Shares Outstanding 36,372
Common Stock Total Equity6
Current Deferred Revenue5,035
Liabilities and Stockholders Equity 62,153
Net Debt -47,417
Net Invested Capital 10,657
Net Tangible Assets 10,657
Net Working Capital 35,858
Property Plant and Equipment Gross 270
Short Long Term Debt Total 6,272



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
3,100
2,189
14,683
174,294
185,327
205,570
93,777
69,470
82,121
67,710
67,787
62,153
62,15367,78767,71082,12169,47093,777205,570185,327174,29414,6832,1893,100
   > Total Current Assets 
3,000
2,106
14,266
170,566
182,069
201,153
81,146
56,992
67,557
62,971
61,855
56,134
56,13461,85562,97167,55756,99281,146201,153182,069170,56614,2662,1063,000
       Cash And Cash Equivalents 
900
329
13,213
170,566
182,069
201,153
81,146
56,992
65,134
60,541
59,424
53,689
53,68959,42460,54165,13456,99281,146201,153182,069170,56613,213329900
       Short-term Investments 
0
75
75
0
0
0
0
0
0
0
0
0
00000000075750
       Net Receivables 
600
84
0
0
0
0
0
606
2,504
262
33
85
85332622,5046060000084600
       Other Current Assets 
1,500
333
131
2,398
772
678
301
16
44
16
3,321
4,281
4,2813,3211644163016787722,3981313331,500
   > Long-term Assets 
100
83
417
3,728
3,258
4,417
12,631
12,478
14,564
4,739
5,932
6,019
6,0195,9324,73914,56412,47812,6314,4173,2583,72841783100
       Property Plant Equipment 
100
28
21
714
389
265
8,888
8,651
8,697
2,958
2,207
1,462
1,4622,2072,9588,6978,6518,8882653897142128100
       Intangible Assets 
0
0
0
0
0
0
0
341
219
97
0
0
00972193410000000
       Other Assets 
0
55
396
616
327
0
2,383
2,416
3,184
5,398
2,435
2,451
2,4512,4355,3983,1842,4162,3830327616396550
> Total Liabilities 
2,200
7,284
3,983
6,925
8,827
54,503
11,021
9,525
13,072
19,655
25,565
51,496
51,49625,56519,65513,0729,52511,02154,5038,8276,9253,9837,2842,200
   > Total Current Liabilities 
1,700
6,851
3,983
6,925
8,827
54,503
5,593
1,937
2,574
11,138
19,192
20,538
20,53819,19211,1382,5741,9375,59354,5038,8276,9253,9836,8511,700
       Short-term Debt 
0
4,460
0
0
0
12,899
0
1,511
2,393
2,086
2,297
2,195
2,1952,2972,0862,3931,511012,8990004,4600
       Accounts payable 
600
991
315
1,259
1,671
14,503
5,593
1,937
2,574
4,823
2,657
8,765
8,7652,6574,8232,5741,9375,59314,5031,6711,259315991600
       Other Current Liabilities 
1,100
1,400
3,668
5,666
7,156
12,899
4,093
1,365
-2,393
-2,086
6,119
4,543
4,5436,119-2,086-2,3931,3654,09312,8997,1565,6663,6681,4001,100
   > Long-term Liabilities 
500
433
0
0
7,156
52,899
5,428
7,588
10,498
8,517
6,373
30,958
30,9586,3738,51710,4987,5885,42852,8997,15600433500
       Long term Debt Total 
0
0
0
0
0
0
5,428
7,324
0
0
0
0
00007,3245,428000000
       Other Liabilities 
0
433
495
0
0
0
5,428
7,588
264
3,763
3,548
27,502
27,5023,5483,7632647,5885,4280004954330
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
3,763
0
0
003,763000000000
> Total Stockholder Equity
900
-5,095
10,700
167,369
176,500
151,067
82,756
59,945
69,049
48,055
42,222
10,657
10,65742,22248,05569,04959,94582,756151,067176,500167,36910,700-5,095900
   Common Stock
0
0
1
2
3
3
4
1
2
2
2
6
622214332100
   Retained Earnings -616,127-539,805-500,654-470,111-450,565-374,232-289,253-193,436-111,259-55,347-35,249-22,000
   Capital Surplus 
0
0
0
0
369,933
440,667
456,984
510,509
539,158
548,707
0
626,778
626,7780548,707539,158510,509456,984440,667369,9330000
   Treasury Stock000000000000
   Other Stockholders Equity 
22,900
507
66,046
104,456
370,251
440,667
457,827
512,388
539,158
548,707
582,025
626,778
626,778582,025548,707539,158512,388457,827440,667370,251104,45666,04650722,900



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,994
Cost of Revenue--
Gross Profit-6,994
 
Operating Income (+$)
Gross Profit-
Operating Expense-66,272
Operating Income-59,278-66,272
 
Operating Expense (+$)
Research Development53,388
Selling General Administrative12,884
Selling And Marketing Expenses-
Operating Expense66,27266,272
 
Net Interest Income (+$)
Interest Income1,461
Interest Expense--
Other Finance Cost-0
Net Interest Income1,461
 
Pretax Income (+$)
Operating Income-59,278
Net Interest Income1,461
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-39,847-77,248
EBIT - interestExpense = 0
-39,847
-39,847
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--39,847
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-39,847
Tax Provision--
Net Income From Continuing Ops-39,847-39,847
Net Income-39,847
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net17,970-1,461
 

Technical Analysis of Aravive
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aravive. The general trend of Aravive is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aravive's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aravive Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.11 < 0.115 < 0.1277.

The bearish price targets are: .

Tweet this
Aravive Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aravive Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aravive Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aravive Inc. The current macd is -0.02300508.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aravive price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Aravive. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Aravive price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aravive Inc Daily Moving Average Convergence/Divergence (MACD) ChartAravive Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aravive Inc. The current adx is 30.02.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Aravive shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Aravive Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aravive Inc. The current sar is 0.07268767.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aravive Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aravive Inc. The current rsi is 20.54. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Aravive Inc Daily Relative Strength Index (RSI) ChartAravive Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aravive Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aravive price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aravive Inc Daily Stochastic Oscillator ChartAravive Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aravive Inc. The current cci is -106.73921217.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Aravive Inc Daily Commodity Channel Index (CCI) ChartAravive Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aravive Inc. The current cmo is -69.73546065.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aravive Inc Daily Chande Momentum Oscillator (CMO) ChartAravive Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aravive Inc. The current willr is -99.88597491.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Aravive Inc Daily Williams %R ChartAravive Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aravive Inc.

Aravive Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aravive Inc. The current atr is 0.01138131.

Aravive Inc Daily Average True Range (ATR) ChartAravive Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aravive Inc. The current obv is 81,630,572.

Aravive Inc Daily On-Balance Volume (OBV) ChartAravive Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aravive Inc. The current mfi is 14.69.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Aravive Inc Daily Money Flow Index (MFI) ChartAravive Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aravive Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Aravive Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aravive Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5020.542
Ma 20Greater thanMa 500.095
Ma 50Greater thanMa 1000.118
Ma 100Greater thanMa 2000.130
OpenGreater thanClose0.044
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aravive with someone you think should read this too:
  • Are you bullish or bearish on Aravive? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aravive? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aravive Inc

I send you an email if I find something interesting about Aravive Inc.


Stay informed about Aravive Inc.

Receive notifications about Aravive Inc in your mailbox!